Patient P-01827
Synthetic patientNBL-101 · Day 115 · 55–64 · F · baseline S15Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Improving
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
20%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S15
- Day 20 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 20.
Primary contributors, last 14 days
- Toxicity-18
- Nutritional resilience+7
- GI instability+2
- Treatment adherence-2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion21.9/100
worsening · +6.4 vs previous 14 d
Toxicity
Blood14.1/100
improving · -6.3 vs previous 14 d
Sleep quality
Wearable64.7/100
worsening · -5.0 vs previous 14 d
Energy level
Daily log5.5/10
stable · -0.0 vs previous 14 d
Stress level
Daily log3.4/10
stable · +0.1 vs previous 14 d
Steps
Wearable3,996
improving · +339 vs previous 14 d
Adherence
Companion80.2 %
stable · +1.3 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 61 from the failing basin, 53 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More spicyGI -3.5 next day on high-intake days · n 9
Would not help
- Nothing clearly counter-productive in the record.
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Spicy / capsaicin-3.5supporter · 95%
- Alcohol+1.2no signal · 27%
- Dietary fat load+0.9no signal · 15%
- Histamine load-0.7no signal · 17%
- Simple carbohydrates+0.3no signal · 15%
- Insoluble fibre+0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
- Autonomic recovery ↑20
- Wearable3,996 steps/day
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 3.8 · butyrate capacity 63/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 66 ms
- Sleep
- 7.5 h
- Steps
- 3,598
- Resting HR
- 66 bpm
Daily log: GI score 22, nutritional resilience 65, adherence 80.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.